Related references
Note: Only part of the references are listed.Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study
Roja Toosi et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Early-onset neutropenia after rituximab therapy for bullous pemphigoid
B. L. Adler et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2019)
Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
Kamran Balighi et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)
Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study
Harrys A. Torres et al.
HEPATOLOGY (2018)
Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
Soheil Tavakolpour et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Rituximab before and during pregnancy A systematic review, and a case series in MS and NMOSD
Gitanjali Das et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Pascal Joly et al.
LANCET (2017)
Low level of Rituximab in human breast milk in a patient treated during lactation
Yngvill Bragnes et al.
RHEUMATOLOGY (2017)
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017
K. E. Harman et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Carina Gotestam Skorpen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus
C. Boulard et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature
William E. Monaco et al.
CLINICAL RHEUMATOLOGY (2016)
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
Soheil Tavakolpour et al.
HEPATITIS MONTHLY (2016)
Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris
Keshavamurthy Vinay et al.
JAMA DERMATOLOGY (2015)
Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
M. Hertl et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Pemphigus Disease Activity Measurements Pemphigus Disease Area Index, Autoimmune Bullous Skin Disorder Intensity Score, and Pemphigus Vulgaris Activity Score
Ziba Rahbar et al.
JAMA DERMATOLOGY (2014)
Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial
Balighi Kamran et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Spectrum of autoimmune bullous diseases in Iran: a 10-year review
Maryam Daneshpazhooh et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Reliability and Convergent Validity of Two Outcome Instruments for Pemphigus
Misha Rosenbach et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Exacerbation of pemphigus after influenza vaccination
C. De Simone et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
Mariana C. Castells et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee E. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
A. Razzaque Ahmed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pemphigus: Analysis of 1209 cases
C Chams-Davatchi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2005)
Pemphigus following hepatitis B vaccination - coincidence or causality?
Y Berkun et al.
AUTOIMMUNITY (2005)
Share Paper
